不同方法治疗分隔的结核性胸膜炎疗效观察  

Clinical efficacy of different therapeutics in septal tuberculous pleuritis

作　　者：黄国华[1] 古辉[1] 杜燕芳[1] 岳阳[1] 

机构地区：[1]广东省佛山市高明区人民医院,广东佛山528500

出　　处：《广东医学院学报》2015年第5期610-612,共3页Journal of Guangdong Medical College

摘　　要：目的探讨不同方法治疗分隔的结核性胸膜炎的效果。方法 120例结核性胸膜炎患者随机分为观察组和对照组,分别给予胸腔镜、尿激酶治疗。观察两组疗效、转手术率、胸膜增厚发生率、胸水消失时间、住院时间、胸膜厚度。结果与对照组比较,观察组疗效较好,转手术率和胸膜增厚发生率较低,胸水消失时间和住院时间较短,胸膜厚度较薄(P<0.01或0.05)。结论胸腔镜是分隔的结核性胸膜炎安全、有效疗法。Objective To observe the clinical efficacy of different therapeutic regimens in septal tuberculous pleuritis（STP）. Methods A total of 120 patients with STP were randomly divided into observation and control groups, and each group received the thoracoscopy and intrapleural urokinase, respectively. Clinical efficacy, incidence of converting？operation and pleural thickening, time of pleural effusion extinction and hospitalization, and pleural thickness were compared in both groups. Results Compared with control group, clinical efficacy was better, incidence of converting operation and pleural thickening was lower, time of pleural effusion extinction and hospitalization was shorter, and pleural thickness was thinner in observation group（P〈0.01 or 0.05）. Conclusion The thoracoscopy is safe and effective for STP.

关 键 词：结核性胸膜炎 胸腔镜 尿激酶 

分 类 号：R561.1[医药卫生—呼吸系统]